These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26040619)

  • 1. Exceptional Responders Inspire Change: Lessons for Drug Development From the Bedside to the Bench and Back.
    Chau NG; Lorch JH
    Oncologist; 2015 Jul; 20(7):699-701. PubMed ID: 26040619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of the NCI precision medicine trials-NCI MATCH and MPACT.
    Do K; O'Sullivan Coyne G; Chen AP
    Chin Clin Oncol; 2015 Sep; 4(3):31. PubMed ID: 26408298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What have we learned from exceptional tumour responses?: Review and perspectives.
    Mehra N; Lorente D; de Bono JS
    Curr Opin Oncol; 2015 May; 27(3):267-75. PubMed ID: 25811347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy.
    Farwell MD; Clark AS; Mankoff DA
    JAMA Oncol; 2015 Jul; 1(4):421-2. PubMed ID: 26181243
    [No Abstract]   [Full Text] [Related]  

  • 5. Personalized-medicine trials on the rise.
    Benowitz S
    J Natl Cancer Inst; 2012 Oct; 104(19):1425-6. PubMed ID: 23008496
    [No Abstract]   [Full Text] [Related]  

  • 6. Initiative for Molecular Profiling and Advanced Cancer Therapy and challenges in the implementation of precision medicine.
    Tsimberidou AM
    Curr Probl Cancer; 2017; 41(3):176-181. PubMed ID: 28410846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Society of Clinical Oncology Developing First Clinical Trial.
    Brower V
    J Natl Cancer Inst; 2015 Nov; 107(11):djv356. PubMed ID: 26538625
    [No Abstract]   [Full Text] [Related]  

  • 8. Translational modeling and simulation approaches for molecularly targeted small molecule anticancer agents from bench to bedside.
    Yamazaki S; Spilker ME; Vicini P
    Expert Opin Drug Metab Toxicol; 2016; 12(3):253-65. PubMed ID: 26799750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Translational research - towards personalized medicine].
    Tokui T
    Nihon Yakurigaku Zasshi; 2013 Mar; 141(3):122-5. PubMed ID: 23470475
    [No Abstract]   [Full Text] [Related]  

  • 10. Transforming Biomarker Development with Exceptional Responders.
    Jonsson P; Taylor BS
    Trends Cancer; 2018 Jan; 4(1):3-6. PubMed ID: 29413420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translating predictive biomarkers within oncology clinical development programs.
    Beckman RA; Chen C
    Biomark Med; 2015; 9(9):851-62. PubMed ID: 26330133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual Biomarkers Using Molecular Personalized Medicine Approaches.
    Zenner HP
    ORL J Otorhinolaryngol Relat Spec; 2017; 79(1-2):7-13. PubMed ID: 28231575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Inhibitors: Novel Strategies for Response Optimization.
    Kurzrock R
    Semin Oncol; 2015 Dec; 42(6):773-4. PubMed ID: 26615124
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of access to targeted cancer therapy.
    Burki TK
    Lancet Oncol; 2015 Oct; 16(13):e482. PubMed ID: 26321211
    [No Abstract]   [Full Text] [Related]  

  • 15. Paul Workman: Drugging the Cancer Genome.
    Trends Cancer; 2016 Oct; 2(10):544-548. PubMed ID: 27904887
    [No Abstract]   [Full Text] [Related]  

  • 16. Using Somatic Mutations to Guide Treatment Decisions: Context Matters.
    Horlings HM; Shah SP; Huntsman DG
    JAMA Oncol; 2015 Jun; 1(3):275-6. PubMed ID: 26181166
    [No Abstract]   [Full Text] [Related]  

  • 17. A Precision Medicine Approach to Clinical Trials.
    Rubin R
    JAMA; 2016 Nov; 316(19):1953-1955. PubMed ID: 27760248
    [No Abstract]   [Full Text] [Related]  

  • 18. Precision oncology: A new era of cancer clinical trials.
    Renfro LA; An MW; Mandrekar SJ
    Cancer Lett; 2017 Feb; 387():121-126. PubMed ID: 26987624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of genomics on personalized cancer medicine.
    Arteaga CL; Baselga J
    Clin Cancer Res; 2012 Feb; 18(3):612-8. PubMed ID: 22298893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational research: precision medicine, personalized medicine, targeted therapies: marketing or science?
    Marquet P; Longeray PH; Barlesi F; ; Ameye V; Augé P; Cazeneuve B; Chatelut E; Diaz I; Diviné M; Froguel P; Goni S; Gueyffier F; Hoog-Labouret N; Mourah S; Morin-Surroca M; Perche O; Perin-Dureau F; Pigeon M; Tisseau A; Verstuyft C
    Therapie; 2015; 70(1):1-19. PubMed ID: 25679189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.